OQROGet OQRO Pro
Politician trade (House)

Thermo Fisher Scientific (TMO)Rep. Michael Rulli (OH06) disclosed a sale $1K–$15K

Rep. Michael Rulli (OH06) disclosed a sale of Thermo Fisher Scientific in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
603 days
Disclosure lag
Traded
Dec 12, 2024
Disclosed
Aug 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 25, 2024Insider · 2 peopleInsiders: 2 sales (~$1.3M)
  2. Oct 28, 2024Insider · 1 personInsiders: 7 sales (~$5.5M)
  3. Oct 29, 2024Insider · 1 personInsiders: 6 sales (~$5.5M)
  4. Oct 30, 2024Insider · 1 personInsiders: 6 sales (~$5.5M)
  5. Oct 31, 2024Insider · 1 personInsiders: 6 sales (~$5.5M)
  6. Nov 1, 2024Insider · 1 personInsiders: 9 sales (~$3.3M)
  7. Nov 6, 2024Insider · 1 personInsiders: 10 sales (~$5.6M)
  8. Nov 7, 2024Insider · 2 peopleInsiders: 1 purchase (~$9K), 7 sales (~$5.6M)
  9. Nov 8, 2024Insider · 1 personInsiders: 5 sales (~$5.0M)
  10. Nov 26, 2024FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Daptomycin in the dilution range of 0.03-64 ug/mL
  11. Dec 2, 2024Insider · 1 personInsiders: 7 sales (~$5.3M)
  12. Dec 3, 2024Insider · 1 personInsiders: 7 sales (~$5.3M)
  13. Dec 5, 2024FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mL
  14. Dec 9, 2024InsiderDirector purchased ~$2.1K of TMO shares in the open market

What came next

  1. Dec 19, 2024FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL
  2. Jan 8, 2025FDAFDA device clearance: Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel
  3. Feb 3, 2025InsiderCFO sold ~$5.83M of TMO shares in the open market
  4. Feb 4, 2025Insider · 2 peopleInsiders: 2 sales (~$5.9M)
  5. Feb 10, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of…
  6. Feb 10, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dilution range of…
  7. Feb 19, 2025InsiderDirector sold ~$8.4K of TMO shares in the open market
  8. Feb 24, 2025InsiderOfficer sold ~$9.73M of TMO shares in the open market
  9. Feb 27, 2025FDAFDA device clearance: The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
  10. Mar 3, 2025InsiderOfficer sold ~$945K of TMO shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Rep. Michael Rulli (OH06)

The full history of Rep. Michael Rulli (OH06) is on the profile page.

How this filing works

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data